PCA
Pallas Capital Advisors Portfolio holdings
AUM
$2.63B
1-Year Return
7.61%
This Quarter Return
+9.01%
1 Year Return
+7.61%
3 Year Return
+38.25%
5 Year Return
–
10 Year Return
–
AUM
$2.63B
AUM Growth
+$217M
(+9%)
Cap. Flow
+$71.4M
Cap. Flow
% of AUM
2.72%
Top 10 Holdings %
Top 10 Hldgs %
32.98%
Holding
947
New
185
Increased
338
Reduced
311
Closed
89
Top Buys
Top Sells
| 1 |
Goldman Sachs ActiveBeta International Equity ETF
GSIE
|
+$20M |
| 2 |
iShares MSCI Intl Quality Factor ETF
IQLT
|
+$19.4M |
| 3 |
Schwab International Equity ETF
SCHF
|
+$10.5M |
| 4 |
Broadcom
AVGO
|
+$8.45M |
| 5 |
Synopsys
SNPS
|
+$7.4M |
Sector Composition
| 1 | Healthcare | 20.15% |
| 2 | Technology | 14.42% |
| 3 | Financials | 7.34% |
| 4 | Consumer Discretionary | 5.99% |
| 5 | Industrials | 5.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
801
Digital Turbine
APPS
$495M
| $82.8K | ﹤0.01% |
14,031
-7,364
| -34% | -$43.4K |
|
802
Unisys
UIS
$279M
| $82.6K | ﹤0.01% |
18,241
+7,620
| +72% | +$34.5K |
|
803
Nuvation Bio
NUVB
$1.15B
| $82.5K | ﹤0.01% |
42,319
+22,040
| +109% | +$43K |
|
804
Petco
WOOF
$1.02B
| $81.4K | ﹤0.01% |
+28,769
| New | +$81.4K |
|
|
NXDR
805
Nextdoor Holdings
NXDR
$786M
| $80.9K | ﹤0.01% |
+48,717
| New | +$80.9K |
|
806
Bumble
BMBL
$689M
| $79K | ﹤0.01% |
+11,994
| New | +$79K |
|
807
Kearny Financial
KRNY
$413M
| $76.9K | ﹤0.01% |
11,908
-4,626
| -28% | -$29.9K |
|
808
Kura Oncology
KURA
$695M
| $76.8K | ﹤0.01% |
13,304
+3,241
| +32% | +$18.7K |
|
809
Blend Labs
BLND
$1.1B
| $73.7K | ﹤0.01% |
22,328
+7,194
| +48% | +$23.7K |
|
810
Sabre
SABR
$698M
| $72.5K | ﹤0.01% |
+22,946
| New | +$72.5K |
|
811
Organogenesis Holdings
ORGO
$620M
| $72.1K | ﹤0.01% |
19,701
-3,755
| -16% | -$13.7K |
|
812
EVgo
EVGO
$525M
| $69.3K | ﹤0.01% |
18,975
-4,141
| -18% | -$15.1K |
|
813
Cerus
CERS
$247M
| $68.7K | ﹤0.01% |
48,754
+21,870
| +81% | +$30.8K |
|
814
UWM Holdings
UWMC
$1.4B
| $68.2K | ﹤0.01% |
16,463
-30,838
| -65% | -$128K |
|
815
Aldeyra Therapeutics
ALDX
$346M
| $68K | ﹤0.01% |
+17,762
| New | +$68K |
|
816
Hanesbrands
HBI
$2.25B
| $63.7K | ﹤0.01% |
+13,916
| New | +$63.7K |
|
817
Monte Rosa Therapeutics
GLUE
$298M
| $59.5K | ﹤0.01% |
+13,182
| New | +$59.5K |
|
818
Myriad Genetics
MYGN
$649M
| $57.4K | ﹤0.01% |
+10,808
| New | +$57.4K |
|
819
Ironwood Pharmaceuticals
IRWD
$180M
| $57K | ﹤0.01% |
79,512
+65,172
| +454% | +$46.7K |
|
820
Repay Holdings
RPAY
$513M
| $56.7K | ﹤0.01% |
+11,760
| New | +$56.7K |
|
821
Oil States International
OIS
$334M
| $56.3K | ﹤0.01% |
10,495
-245
| -2% | -$1.31K |
|
822
Gray Television
GTN
$597M
| $55.2K | ﹤0.01% |
+12,183
| New | +$55.2K |
|
823
Eventbrite
EB
$263M
| $54.5K | ﹤0.01% |
20,740
+3,812
| +23% | +$10K |
|
824
Solid Biosciences
SLDB
$389M
| $53.8K | ﹤0.01% |
+11,042
| New | +$53.8K |
|
825
Future Fuel
FF
$169M
| $53.1K | ﹤0.01% |
13,690
-3,846
| -22% | -$14.9K |
|